Watch GSK amid evidence hearing on Zantac litigation
https://seekingalpha.com/news/4057520-watch-gsk-amid-hearing-on-zantac-litigation?source=feed_sector_healthcare
Jan 23, 2024 - Investors should watch GSK amid a pre-trial hearing over litigation related to the heartburn medication Zantac, which could result in billions of...
0
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
https://www.zacks.com/stock/news/2214220/are-you-a-momentum-investor-this-1-stock-could-be-the-perfect-pick?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2214220
Jan 23, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
0
GSK (GSK) Stock Dips While Market Gains: Key Facts
https://www.zacks.com/stock/news/2213817/gsk-gsk-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2213817
Jan 22, 2024 - GSK (GSK) closed at $39.53 in the latest trading session, marking a -0.38% move from the prior day.
0
GSK (GSK) Declines More Than Market: Some Information for Investors
https://www.zacks.com/stock/news/2211130/gsk-gsk-declines-more-than-market-some-information-for-investors?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v3-2211130
Jan 16, 2024 - GSK (GSK) closed at $39.88 in the latest trading session, marking a -0.55% move from the prior day.
0
GSK to sell 3.2% stake in spinoff Haleon: report
https://seekingalpha.com/news/4055337-gsk-to-sell-stake-in-spinoff-haleon-report?source=feed_sector_healthcare
Jan 16, 2024 - GSK (GSK) reportedly plans to sell a 3.2% stake in consumer healthcare products company Haleon (HLN), which it spun off in 2019. Read more here.
0
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
https://www.cnbc.com/2024/01/14/cancer-drugs-renewed-interest-in-adcs-will-continue-in-2024.html
Jan 14, 2024 - The JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer drugs.
0
Biotech Stock Roundup: REGN Down on Eylea Update, MRNA Gains on Preliminary Results
https://www.zacks.com/stock/news/2208960/biotech-stock-roundup-regn-down-on-eylea-update-mrna-gains-on-preliminary-results?cid=CS-ZC-FT-analyst_blog|stock_roundup-2208960
Jan 11, 2024 - Preliminary Q4 and 2023 results from Regeneron (REGN) and Moderna (MRNA) were key highlights this week in the biotech sector.
0
GSK to Buy Private Biotech, Strengthen Respiratory Pipeline
https://www.zacks.com/stock/news/2208092/gsk-to-buy-private-biotech-strengthen-respiratory-pipeline?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2208092
Jan 10, 2024 - GSK's proposed acquisition of Aiolos is set to add the latter's long-acting anti-TSLP monoclonal antibody, AIO-001, to GSK's broad portfolio of respiratory products.
0
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
https://www.zacks.com/stock/news/2207963/why-investors-need-to-take-advantage-of-these-2-medical-stocks-now?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2207963
Jan 09, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
0
GSK (GSK) Rises But Trails Market: What Investors Should Know
https://www.zacks.com/stock/news/2207242/gsk-gsk-rises-but-trails-market-what-investors-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v2-2207242
Jan 08, 2024 - The latest trading day saw GSK (GSK) settling at $39.64, representing a +1.1% change from its previous close.
0